Cargando…
Early (Days 1–4) post-treatment serum hCG level changes predict single-dose methotrexate treatment success in tubal ectopic pregnancy
STUDY QUESTION: What is the capacity of the change between Day 1 and Day 4 post-treatment serum human chorionic gonadotropin (hCG) levels for predicting single-dose methotrexate treatment success in tubal ectopic pregnancy? SUMMARY ANSWER: Any fall in Days 1–4 serum hCG signified an 85% (95% CI 76.8...
Autores principales: | Mackenzie, Scott C, Moakes, Catherine A, Doust, Ann M, Mol, Ben W, Duncan, W Colin, Tong, Stephen, Horne, Andrew W, Whitaker, Lucy H R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320483/ https://www.ncbi.nlm.nih.gov/pubmed/37178269 http://dx.doi.org/10.1093/humrep/dead089 |
Ejemplares similares
-
Subsequent pregnancy outcomes among women with tubal ectopic pregnancy treated with methotrexate
por: Mackenzie, Scott C, et al.
Publicado: (2023) -
Using a decline in serum hCG between days 0–4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study
por: Skubisz, Monika, et al.
Publicado: (2013) -
Gefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000–10,000 IU/L: Phase II Open Label, Single Arm Multi-Centre Trial()
por: Skubisz, Monika M., et al.
Publicado: (2018) -
β-hCG resolution times during expectant management of tubal ectopic pregnancies
por: Mavrelos, D., et al.
Publicado: (2015) -
Combination gefitinib and methotrexate treatment for non-tubal ectopic pregnancies: a case series
por: Horne, A.W., et al.
Publicado: (2014)